SCHEMBL8285228

SCHEMBL8285228

CCCCC(=O)c1cc(C)c2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.42
CSF1R P07333 1/20 0.36
KDM4E B2RXH2 5/20 0.35
KMT2A Q03164 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 1/20 0.35
HSD17B10 Q99714 4/20 0.35
HPGD P15428 3/20 0.35
POLB P06746 1/20 0.35
HTT P42858 2/20 0.35
MAPT P10636 4/20 0.34
GAA P10253 3/20 0.33
MAPK1 P28482 2/20 0.33
GFER P55789 1/20 0.33
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33
ALOX15 P16050 1/20 0.32
CCNB2 O95067 1/20 0.32
CCNE2 O96020 1/20 0.32
CDK1 P06493 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285167 0.97 PDE11A (0.41) PDE11ACSF1RKDM4EKMT2AALDH1A1
SCHEMBL8285174 0.94 PDE11A (0.43) PDE11ACSF1RKDM4EALDH1A1HSD17B10
SCHEMBL8287518 0.90 PDE11A (0.44) PDE11ACSF1RKDM4EKMT2AALDH1A1
SCHEMBL8286390 0.86 PDE11A (0.40) PDE11ACSF1RKDM4EALDH1A1HSD17B10
SCHEMBL5872175 0.86 PDE11A (0.47) PDE11ACSF1RKDM4EALDH1A1HSD17B10
SCHEMBL8285181 0.85 PDE11A (0.42) PDE11ACSF1RKDM4EKMT2AALDH1A1
SCHEMBL8286396 0.85 PDE11A (0.44) PDE11ACSF1RKDM4EALDH1A1HSD17B10
SCHEMBL5871541 0.85 PDE11A (0.46) PDE11ACSF1RKDM4EALDH1A1HSD17B10
SCHEMBL8286372 0.84 CSF1R (0.47) PDE11ACSF1RKDM4EKMT2AALDH1A1
SCHEMBL8287397 0.84 PDE11A (0.46) PDE11ACSF1RKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed